Sonoma Pharmaceuticals, Inc.

NasdaqCM:SNOA Rapporto sulle azioni

Cap. di mercato: US$3.7m

Sonoma Pharmaceuticals Crescita futura

Future criteri di controllo 2/6

Sonoma Pharmaceuticals is forecast to grow earnings and revenue by 53.7% and 27.1% per annum respectively while EPS is expected to grow by 81.2% per annum.

Informazioni chiave

53.7%

Tasso di crescita degli utili

81.2%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili23.7%
Tasso di crescita dei ricavi27.1%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento15 Jul 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Oct 17
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 33% Lower

Aug 27
Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 33% Lower

The Market Lifts Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Shares 75% But It Can Do More

Jul 12
The Market Lifts Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Shares 75% But It Can Do More

Investors Aren't Entirely Convinced By Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues

May 26
Investors Aren't Entirely Convinced By Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues

Sonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.99M

Aug 11

Does Sonoma Pharmaceuticals (NASDAQ:SNOA) Have A Healthy Balance Sheet?

Sep 30
Does Sonoma Pharmaceuticals (NASDAQ:SNOA) Have A Healthy Balance Sheet?

Sonoma Pharmaceuticals reports FQ2 results

Nov 20

Previsioni di crescita degli utili e dei ricavi

NasdaqCM:SNOA - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202621-2N/A12
3/31/202516-3N/A-22
6/30/202413-5-3-3N/A
3/31/202413-5-2-2N/A
12/31/202312-5-5-5N/A
9/30/202312-6-4-4N/A
6/30/202313-6-5-5N/A
3/31/202313-5-6-6N/A
12/31/202213-7-5-5N/A
9/30/202213-6-5-5N/A
6/30/202213-5-5-5N/A
3/31/202213-5-4-4N/A
12/31/202112-6-4-4N/A
9/30/202115-5-3-3N/A
6/30/202117-5-2-2N/A
3/31/202119-5-4-3N/A
12/31/202021-3-6-5N/A
9/30/202020-4-7-7N/A
6/30/202019-5-8-8N/A
3/31/202018-4-5-5N/A
12/31/201918-5-4-4N/A
9/30/201919-6-5-5N/A
6/30/201919-8-8-8N/A
3/31/201919-12-12-12N/A
12/31/201818-13-12-12N/A
9/30/201818-14-12-12N/A
6/30/201817-14-11-11N/A
3/31/201817-14N/A-12N/A
12/31/201717-12N/A-12N/A
9/30/201716-9N/A-11N/A
6/30/201714-9N/A-10N/A
3/31/201713-9N/A-8N/A
12/31/201611-9N/A-7N/A
9/30/201610-14N/A-8N/A
6/30/20168-16N/A-9N/A
3/31/20169-15N/A-9N/A
12/31/201511-13N/A-10N/A
9/30/201512-14N/A-8N/A
6/30/201514-10N/A-8N/A
3/31/201514-8N/A-7N/A
12/31/2014131N/A-6N/A
9/30/2014136N/A-5N/A
6/30/2014145N/A-5N/A
3/31/2014144N/A-5N/A
12/31/201314-6N/A-4N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: SNOA is forecast to remain unprofitable over the next 3 years.

Guadagni vs Mercato: SNOA is forecast to remain unprofitable over the next 3 years.

Guadagni ad alta crescita: SNOA is forecast to remain unprofitable over the next 3 years.

Ricavi vs Mercato: SNOA's revenue (27.1% per year) is forecast to grow faster than the US market (8.9% per year).

Ricavi ad alta crescita: SNOA's revenue (27.1% per year) is forecast to grow faster than 20% per year.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if SNOA's Return on Equity is forecast to be high in 3 years time


Scoprire le aziende in crescita